FLAIR

Trial description
Front-Line therapy in CLL: Assessment of Ibrutinib + Rituximab
Contact name
Dr George Follows
Trial start date
Monday, January 19, 2015
Trial end date
Monday, February 4, 2019
Trial tumour type
Haematological
Show on Radiotherapy
No